Yuki Shimba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuki Shimba has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Shinji Miura
Laboratory of Nutritional Biochemistry, Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, Shizuoka, Japan
5 shared publications Akihito Morita
Laboratory of Nutritional Biochemistry, Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, 52-1 Yada, Suruga Ward, Shizuoka City, Shizuoka, 422-8526, Japan
3 shared publicationsKeigo Katayama
Laboratory of Nutritional Biochemistry, Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, 52-1 Yada, Suruga Ward, Shizuoka City, Shizuoka, 422-8526, Japan
2 shared publicationsMasahiko Ikeda
Faculty of Social and Environmental Studies, Tokoha University
2 shared publications- Noriyuki Miyoshi
Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
2 shared publications Sayuri Shibayama
Laboratory of Clinical Nutrition, School of Food and Nutritional Sciences, University of Shizuoka, 52-1, Yada, Suruga Ward, Shizuoka City, Shizuoka, 422-8526, Japan
2 shared publications
Latest Publications
- Open Access
- 8 June 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47, 102667
An exploratory investigation of β-aminoisobutyric acid as a biomarker: possible relationships between urinary BAIBA and lifestyle habits
- 8 June 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47, 102667
Open AccessAn exploratory investigation of β-aminoisobutyric acid as a biomarker: possible relationships between urinary BAIBA and lifestyle habits
- 30 August 2025
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 69 (22) , e70228
Water‐Soluble Pu‐Erh Tea Extracts at Reasonable Oral Doses Down‐Regulate the Expression of Genes Involved in Fat Synthesis and Prevent Weight Gain in High‐Fat Diet‐Fed Mice
Pu‐erh tea attenuates obesity and lipid metabolism by inhibiting pancreatic lipase, but prior studies used doses much higher than typical human consumption, which raised concerns about renal toxicity. This study aimed to investigate the effects of human drinkable doses of Pu‐erh tea extract (PTE) on obesity and lipid metabolism. High‐fat diet (HFD)‐fed male C57BL/6J mice were orally administered distilled water (HFD group), 107.5 mg/kg PTE (High group, human equivalent: 1200 mL), or half of the High group's dose (Low group, human equivalent: 600 mL) per day. Hepatic and visceral fat accumulation, and body weight normalized by caloric consumption were reduced in the High group compared to the HFD group. Additionally, PTE decreased plasma triglyceride (TG) and the gene expression of fat synthesis genes in the liver, concomitant with a reduction in histologically observed hepatic fat deposits. Furthermore, mRNA expression levels related to TG synthesis in adipocytes, decreased in response to PTE treatment. PTE administration, at a human drinkable dose, inhibited fat accumulation. This might be related to the decreased expressions of these genes in adipocytes or the liver involved in these functions, which would presumably contribute to the prevention of weight gain.
- 30 August 2025
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 69 (22) , e70228
Water‐Soluble Pu‐Erh Tea Extracts at Reasonable Oral Doses Down‐Regulate the Expression of Genes Involved in Fat Synthesis and Prevent Weight Gain in High‐Fat Diet‐Fed Mice
Pu‐erh tea attenuates obesity and lipid metabolism by inhibiting pancreatic lipase, but prior studies used doses much higher than typical human consumption, which raised concerns about renal toxicity. This study aimed to investigate the effects of human drinkable doses of Pu‐erh tea extract (PTE) on obesity and lipid metabolism. High‐fat diet (HFD)‐fed male C57BL/6J mice were orally administered distilled water (HFD group), 107.5 mg/kg PTE (High group, human equivalent: 1200 mL), or half of the High group's dose (Low group, human equivalent: 600 mL) per day. Hepatic and visceral fat accumulation, and body weight normalized by caloric consumption were reduced in the High group compared to the HFD group. Additionally, PTE decreased plasma triglyceride (TG) and the gene expression of fat synthesis genes in the liver, concomitant with a reduction in histologically observed hepatic fat deposits. Furthermore, mRNA expression levels related to TG synthesis in adipocytes, decreased in response to PTE treatment. PTE administration, at a human drinkable dose, inhibited fat accumulation. This might be related to the decreased expressions of these genes in adipocytes or the liver involved in these functions, which would presumably contribute to the prevention of weight gain.
- Open Access
- 1 January 2023
- Published by Japan Society for Occupational Health in Environmental and Occupational Health Practice
- Vol. 5 (1)
Effect and factors associated with weight and waist circumference reductions in information and communication technology-based specific health guidance
Objectives: Specific health guidance (SHG) has served as a preventive intervention for metabolic syndrome in Japan since 2008. For SHG, health professionals guide diet and physical activity to achieve body weight (BW) and waist circumference (WC) reductions. Since 2013, SHG intervention using information and communication technology (ICT-based SHG) has also been available. Therefore, in this study, we examined the effects of ICT-based SHG, and identified factors associated with BW and WC reductions in response to this intervention. Methods: Our intervention was performed using a smartphone application with videophone guidance and message exchanges provided by health professionals. We analysed 1,994 participants. Primary outcomes included changes in BW and WC after versus before the intervention. We used multiple linear regression analyses to identify factors associated with reductions in BW and WC due to the intervention. Results: The mean ages were 49.3 (standard deviation [SD], 5.8) years for males and 50.5 (SD, 5.8) years for females. The mean BW change was -1.37 kg for both sexes. The mean WC changes were -1.05 for males and -2.05 cm for females. For males, baseline body mass index, pre-intervention action history, and the numbers of videophone communications and messages were significantly associated with larger changes in BW and WC. For females, no factors were significant for BW reduction, while baseline WC and pre-intervention action history were associated with WC reduction. Conclusions: ICT-based SHG reduces BW and WC. Videophone communication and messaging are associated with reductions in BW and WC in males. These results may help to improve the efficacy of ICT-based SHG.
- 1 January 2023
- Published by Japan Society for Occupational Health in Environmental and Occupational Health Practice
- Vol. 5 (1)
Open AccessEffect and factors associated with weight and waist circumference reductions in information and communication technology-based specific health guidance
Objectives: Specific health guidance (SHG) has served as a preventive intervention for metabolic syndrome in Japan since 2008. For SHG, health professionals guide diet and physical activity to achieve body weight (BW) and waist circumference (WC) reductions. Since 2013, SHG intervention using information and communication technology (ICT-based SHG) has also been available. Therefore, in this study, we examined the effects of ICT-based SHG, and identified factors associated with BW and WC reductions in response to this intervention. Methods: Our intervention was performed using a smartphone application with videophone guidance and message exchanges provided by health professionals. We analysed 1,994 participants. Primary outcomes included changes in BW and WC after versus before the intervention. We used multiple linear regression analyses to identify factors associated with reductions in BW and WC due to the intervention. Results: The mean ages were 49.3 (standard deviation [SD], 5.8) years for males and 50.5 (SD, 5.8) years for females. The mean BW change was -1.37 kg for both sexes. The mean WC changes were -1.05 for males and -2.05 cm for females. For males, baseline body mass index, pre-intervention action history, and the numbers of videophone communications and messages were significantly associated with larger changes in BW and WC. For females, no factors were significant for BW reduction, while baseline WC and pre-intervention action history were associated with WC reduction. Conclusions: ICT-based SHG reduces BW and WC. Videophone communication and messaging are associated with reductions in BW and WC in males. These results may help to improve the efficacy of ICT-based SHG.
- Open Access
- 1 June 2020
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 43 (6) , 1016-1019
β-Aminoisobutyric Acid Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice
Endurance exercise training has been shown to induce peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) expression in skeletal muscle. We recently reported that skeletal muscle-specific PGC-1α overexpression suppressed atherosclerosis in apolipoprotein E-knockout (ApoE−/−) mice. β-Aminoisobutyric acid (BAIBA) is a PGC-1α-dependent myokine secreted from myocytes that affects multiple organs. We have also reported that BAIBA suppresses tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) gene expression in endothelial cells. In the present study, we hypothesized that BAIBA suppresses atherosclerosis progression, and tested that hypothesis with ApoE−/− mice. The mice were administered water containing BAIBA for 14 weeks, and were then sacrificed at 20 weeks of age. Atherosclerotic plaque area, plasma BAIBA concentration, and plasma lipoprotein profiles were assessed. Immunohistochemical analyses of the plaque were performed to assess VCAM-1 and MCP-1 protein expression levels and macrophage infiltration. The results showed that BAIBA administration decreased atherosclerosis plaque area by 30%, concomitant with the elevation of plasma BAIBA levels. On the other hand, plasma lipoprotein profiles were not changed by the administration. Immunohistochemical analyses indicated reductions in VCAM-1, MCP-1, and Mac-2 protein expression levels in the plaque. These results suggest that BAIBA administration suppresses atherosclerosis progression without changing plasma lipoprotein profiles. We propose that the mechanisms of this suppression are reductions in both VCAM-1 and MCP-1 expression as well as macrophage infiltration into the plaque.
- 1 June 2020
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 43 (6) , 1016-1019
Open Accessβ-Aminoisobutyric Acid Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice
Endurance exercise training has been shown to induce peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) expression in skeletal muscle. We recently reported that skeletal muscle-specific PGC-1α overexpression suppressed atherosclerosis in apolipoprotein E-knockout (ApoE−/−) mice. β-Aminoisobutyric acid (BAIBA) is a PGC-1α-dependent myokine secreted from myocytes that affects multiple organs. We have also reported that BAIBA suppresses tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) gene expression in endothelial cells. In the present study, we hypothesized that BAIBA suppresses atherosclerosis progression, and tested that hypothesis with ApoE−/− mice. The mice were administered water containing BAIBA for 14 weeks, and were then sacrificed at 20 weeks of age. Atherosclerotic plaque area, plasma BAIBA concentration, and plasma lipoprotein profiles were assessed. Immunohistochemical analyses of the plaque were performed to assess VCAM-1 and MCP-1 protein expression levels and macrophage infiltration. The results showed that BAIBA administration decreased atherosclerosis plaque area by 30%, concomitant with the elevation of plasma BAIBA levels. On the other hand, plasma lipoprotein profiles were not changed by the administration. Immunohistochemical analyses indicated reductions in VCAM-1, MCP-1, and Mac-2 protein expression levels in the plaque. These results suggest that BAIBA administration suppresses atherosclerosis progression without changing plasma lipoprotein profiles. We propose that the mechanisms of this suppression are reductions in both VCAM-1 and MCP-1 expression as well as macrophage infiltration into the plaque.
- Open Access
Green Tea Extracts Attenuate Brain Dysfunction in High-Fat-Diet-Fed SAMP8 Mice
Unhealthy diet promotes progression of metabolic disorders and brain dysfunction with aging. Green tea extracts (GTEs) have various beneficial effects and alleviate metabolic disorders. GTEs have neuroprotective effects in rodent models, but their effects against brain dysfunction in models of aging fed unhealthy diets are still unclear. Here, we showed that GTEs attenuate high-fat (HF) diet-induced brain dysfunction in senescence-accelerated mouse prone-8 (SAMP8), a murine model of senescence. SAMP8 mice were fed a control diet, HF diet, or HF diet with 0.5% GTEs (HFGT) for four months. The HF diet reduced memory retention and induced amyloid β1–42 accumulation, whereas GTEs attenuated these changes. In HF diet-fed mice, lipid oxidative stress, assessed by malondialdehyde levels, was increased. The levels of proteins that promote synaptic plasticity, such as brain-derived neurotrophic factor (BDNF) and postsynaptic density protein 95 (PSD95), were reduced. These alterations related to brain dysfunction were not observed in HFGT diet-fed mice. Overall, our data suggest that GTEs intake might attenuate brain dysfunction in HF diet-fed SAMP8 mice by protecting synaptic plasticity as well as via anti-oxidative effects. In conclusion, GTEs might ameliorate unhealthy diet-induced brain dysfunction that develops with aging.
Open AccessGreen Tea Extracts Attenuate Brain Dysfunction in High-Fat-Diet-Fed SAMP8 Mice
Unhealthy diet promotes progression of metabolic disorders and brain dysfunction with aging. Green tea extracts (GTEs) have various beneficial effects and alleviate metabolic disorders. GTEs have neuroprotective effects in rodent models, but their effects against brain dysfunction in models of aging fed unhealthy diets are still unclear. Here, we showed that GTEs attenuate high-fat (HF) diet-induced brain dysfunction in senescence-accelerated mouse prone-8 (SAMP8), a murine model of senescence. SAMP8 mice were fed a control diet, HF diet, or HF diet with 0.5% GTEs (HFGT) for four months. The HF diet reduced memory retention and induced amyloid β1–42 accumulation, whereas GTEs attenuated these changes. In HF diet-fed mice, lipid oxidative stress, assessed by malondialdehyde levels, was increased. The levels of proteins that promote synaptic plasticity, such as brain-derived neurotrophic factor (BDNF) and postsynaptic density protein 95 (PSD95), were reduced. These alterations related to brain dysfunction were not observed in HFGT diet-fed mice. Overall, our data suggest that GTEs intake might attenuate brain dysfunction in HF diet-fed SAMP8 mice by protecting synaptic plasticity as well as via anti-oxidative effects. In conclusion, GTEs might ameliorate unhealthy diet-induced brain dysfunction that develops with aging.
- Open Access
- 11 March 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Skeletal Muscle-specific PGC-1α Overexpression Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice
Endurance exercise training prevents atherosclerosis. Peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) increases myokine secretion from the skeletal muscle, and these myokines have been shown to affect the function of multiple organs. Since endurance exercise training increases PGC-1α expression in skeletal muscles, we investigated whether skeletal muscle-specific PGC-1α overexpression suppresses atherosclerosis. Apolipoprotein E-knockout (ApoE-KO)/PGC-1α mice, which overexpress PGC-1α in the skeletal muscle of ApoE-KO mice, were sacrificed, and the atherosclerotic plaque area, spontaneous activity, plasma lipid profile, and aortic gene expression were measured. Immunohistochemical analyses were also performed. The atherosclerotic lesions in ApoE-KO/PGC-1α mice were 40% smaller than those in ApoE-KO mice, concomitant with the reduction in vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) mRNA and protein levels in the aorta. Spontaneous activity and plasma lipid profiles were not changed by the overexpression of PGC-1α in the skeletal muscle. In human umbilical vein endothelial cells, Irisin and β-aminoisobutyric acid (BAIBA), PGC-1α-dependent myokines, inhibited the tumor necrosis factor α-induced VCAM-1 gene and protein expression. BAIBA also inhibited TNFα-induced MCP-1 gene expression. These results showed that the skeletal muscle-specific overexpression of PGC-1α suppresses atherosclerosis and that PGC-1α-dependent myokines may be involved in the preventive effects observed.
- 11 March 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Open AccessSkeletal Muscle-specific PGC-1α Overexpression Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice
Endurance exercise training prevents atherosclerosis. Peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) increases myokine secretion from the skeletal muscle, and these myokines have been shown to affect the function of multiple organs. Since endurance exercise training increases PGC-1α expression in skeletal muscles, we investigated whether skeletal muscle-specific PGC-1α overexpression suppresses atherosclerosis. Apolipoprotein E-knockout (ApoE-KO)/PGC-1α mice, which overexpress PGC-1α in the skeletal muscle of ApoE-KO mice, were sacrificed, and the atherosclerotic plaque area, spontaneous activity, plasma lipid profile, and aortic gene expression were measured. Immunohistochemical analyses were also performed. The atherosclerotic lesions in ApoE-KO/PGC-1α mice were 40% smaller than those in ApoE-KO mice, concomitant with the reduction in vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) mRNA and protein levels in the aorta. Spontaneous activity and plasma lipid profiles were not changed by the overexpression of PGC-1α in the skeletal muscle. In human umbilical vein endothelial cells, Irisin and β-aminoisobutyric acid (BAIBA), PGC-1α-dependent myokines, inhibited the tumor necrosis factor α-induced VCAM-1 gene and protein expression. BAIBA also inhibited TNFα-induced MCP-1 gene expression. These results showed that the skeletal muscle-specific overexpression of PGC-1α suppresses atherosclerosis and that PGC-1α-dependent myokines may be involved in the preventive effects observed.
- Open Access
- 9 April 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (4) , e0195753
Green tea extracts ameliorate high-fat diet–induced muscle atrophy in senescence-accelerated mouse prone-8 mice
Muscle atrophy (loss of skeletal muscle mass) causes progressive deterioration of skeletal function. Recently, excessive intake of fats was suggested to induce insulin resistance, followed by muscle atrophy. Green tea extracts (GTEs), which contain polyphenols such as epigallocatechin gallate, have beneficial effects on obesity, hyperglycemia, and insulin resistance, but their effects against muscle atrophy are still unclear. Here, we found that GTEs prevented high-fat (HF) diet–induced muscle weight loss in senescence-accelerated mouse prone-8 (SAMP8), a murine model of senescence. SAMP8 mice were fed a control diet, an HF diet, or HF with 0.5% GTEs (HFGT) diet for 4 months. The HF diet induced muscle weight loss with aging (measured as quadriceps muscle weight), whereas GTEs prevented this loss. In HF diet–fed mice, blood glucose and plasma insulin concentrations increased in comparison with the control group, and these mice had insulin resistance as determined by homeostasis model assessment of insulin resistance (HOMA-IR). In these mice, serum concentrations of leukocyte cell–derived chemotaxin 2 (LECT2), which is known to induce insulin resistance in skeletal muscle, were elevated, and insulin signaling in muscle, as determined by the phosphorylation levels of Akt and p70 S6 kinases, tended to be decreased. In HFGT diet–fed mice, these signs of insulin resistance and elevation of serum LECT2 were not observed. Although our study did not directly show the effect of serum LECT2 on muscle weight, insulin resistance examined using HOMA-IR indicated an intervention effect of serum LECT2 on muscle weight, as revealed by partial correlation analysis. Accordingly, GTEs might have beneficial effects on age-related and HF diet–induced muscle weight loss, which correlates with insulin resistance and is accompanied by a change in serum LECT2.
- 9 April 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (4) , e0195753
Open AccessGreen tea extracts ameliorate high-fat diet–induced muscle atrophy in senescence-accelerated mouse prone-8 mice
Muscle atrophy (loss of skeletal muscle mass) causes progressive deterioration of skeletal function. Recently, excessive intake of fats was suggested to induce insulin resistance, followed by muscle atrophy. Green tea extracts (GTEs), which contain polyphenols such as epigallocatechin gallate, have beneficial effects on obesity, hyperglycemia, and insulin resistance, but their effects against muscle atrophy are still unclear. Here, we found that GTEs prevented high-fat (HF) diet–induced muscle weight loss in senescence-accelerated mouse prone-8 (SAMP8), a murine model of senescence. SAMP8 mice were fed a control diet, an HF diet, or HF with 0.5% GTEs (HFGT) diet for 4 months. The HF diet induced muscle weight loss with aging (measured as quadriceps muscle weight), whereas GTEs prevented this loss. In HF diet–fed mice, blood glucose and plasma insulin concentrations increased in comparison with the control group, and these mice had insulin resistance as determined by homeostasis model assessment of insulin resistance (HOMA-IR). In these mice, serum concentrations of leukocyte cell–derived chemotaxin 2 (LECT2), which is known to induce insulin resistance in skeletal muscle, were elevated, and insulin signaling in muscle, as determined by the phosphorylation levels of Akt and p70 S6 kinases, tended to be decreased. In HFGT diet–fed mice, these signs of insulin resistance and elevation of serum LECT2 were not observed. Although our study did not directly show the effect of serum LECT2 on muscle weight, insulin resistance examined using HOMA-IR indicated an intervention effect of serum LECT2 on muscle weight, as revealed by partial correlation analysis. Accordingly, GTEs might have beneficial effects on age-related and HF diet–induced muscle weight loss, which correlates with insulin resistance and is accompanied by a change in serum LECT2.